Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 7:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2185–2208 of 21,040 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Chronic Pain
Interventions: Cognitive Behavioral Therapy (CBT), Hypnotic Cognitive Therapy (HYP-CT), Mindfulness-Based Cognitive Therapy (MBCT); Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 331 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Seattle, Washington • Tacoma, Washington

Conditions: Major Depressive Disorder
Interventions: Cranial Electrotherapy Stimulation, Sham Cranial Electrotherapy Stimulation; Device
Lead sponsor: Electromedical Products International, Inc.; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Forest, Virginia

Conditions: Renal Cell Carcinoma Stage IV
Interventions: mHealth Smart Phone Application, eHEALS digital literacy test, Weekly Quiz, European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire, Patient Post Intervention Survey; Other · Behavioral
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Multiple Myeloma
Interventions: Carfilzomib, Dexamethasone; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 35
States / cities: Tucson, Arizona • Bakersfield, California • Encinitas, California + 30 more

Conditions: Uterine Fibroids, Polyps
Interventions: MyoSure Tissue Removal System; Device
Lead sponsor: Hologic, Inc.; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 290 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Marlborough, Massachusetts

Conditions: Glioblastoma, Refractory Glioblastoma, Glioblastoma Multiforme
Interventions: Gallium Maltolate; Drug
Lead sponsor: Imaging Biometrics, LLC; Industry
Eligibility: 18 Years and older
U.S. locations: 3
States / cities: Miami, Florida • Lincoln, Nebraska • New York, New York

Conditions: Chronic Lung Disease, Cardiopulmonary Disease
Interventions: Music Condition, Podcast Condition; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 21 Years to 85 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Estrogen Receptor Positive Breast Cancer
Interventions: [18F]Fluoroestradiol (FES) PET/CT; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Centanafadine; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 9 Years to 12 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Adolescent Well-Being, Mental Health Wellness
Interventions: Clinical team access to Placement Success Predictor (PSP) results; Other
Lead sponsor: Outcome Referrals, Inc.; Industry
Eligibility: Not listed
Enrollment: 403 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Framingham, Massachusetts

Conditions: Cervical Intraepithelial Neoplasia
Interventions: PepCan, Candin®; Biological
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Genitourinary Syndrome of Menopause
Interventions: CO2 laser, OCT; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Irvine, California

Conditions: Bone Graft; Complications, ACL Injuries
Interventions: autologous bone grafts, Demineralized bone matrix (DBM); Procedure · Other
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 40 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: Phoenix, Arizona • Scottsdale, Arizona

Conditions: Control Condition, Intervention Condition
Interventions: Technology Enabled Prevention Services, Library-As-Usual Control Condition; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stroke
Interventions: Virtual-reality based dance training; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 90 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Anemia
Interventions: methoxy polyethylene glycol-epoetin beta [Mircera]; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2004
U.S. locations: 6
States / cities: Birmingham, Alabama • San Diego, California • Detroit, Michigan + 2 more

Conditions: Crohn's Disease, Colitis, IBD, Inflammatory Bowel Disease
Interventions: Placebo SC, Placebo IV, Ustekinumab 90 mg SC q8w, Ustekinumab 130 mg IV, Ustekinumab 90 mg SC q12w; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 1,282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 77
States / cities: Tucson, Arizona • La Jolla, California • Los Angeles, California + 74 more

Conditions: Rheumatoid Arthritis, Osteoarthritis, Periodontal Disease
Interventions: Digital xray of jaw and teeth, Blood draw, questionnaires, Periodontal Examination, Bilateral digital xray of hands; Radiation · Procedure · Other
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 617 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Colorectal Cancer Screening
Interventions: Semi-structured interviews-Patients, Semi-structured interviews-Health system; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Progeria, Hutchinson-Gilford Syndrome
Interventions: Lonafarnib, Zoledronic Acid, Pravastatin; Drug
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Not listed
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiovascular Diseases, Cardiovascular Risk Factor, Obesity
Interventions: Mediterranean diet, Olive oil and mixed nuts, American Heart Association; Behavioral · Dietary Supplement
Lead sponsor: Auburn University; Other
Eligibility: 19 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Shoulder Pain
Interventions: Nerve Block - either PECS II or axillary ring; Procedure
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Healthy Volunteers
Interventions: high-power, low-power; Other
Lead sponsor: Youngstown State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Youngstown, Ohio

Conditions: Obesity
Interventions: High-Intensity Functional Training, Army Physical Readiness Training; Behavioral
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 138 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 2
States / cities: Leavenworth, Kansas • Manhattan, Kansas

Search by objective public record fields.

Matching Adults to Treatments for Chronic Pain (MATCH) Study

Efficacy of Cranial Electrotherapy Stimulation (CES) for the Treatment of Major Depressive Disorder

Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy

A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma

MyoSure Hysteroscopic Tissue Removal System Registry Study

Expanded Access to Gallium Maltolate (GaM)

Exercise Strategies to Motivate and Relieve Stress

[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial

Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)

Predict the Best Level of Care Placement for Each Child's Behavioral Health Needs - Effectiveness Study

A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions

Continuous Monitoring and Management of Vaginal Health Via Multifunctional OCT/OCTA/OCE Endoscopy

Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction

TEPS for At-Risk Youth

Alternative Therapies for Improving Physical Function in Individuals With Stroke

A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.

A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)

Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis

Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation

A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

A Mediterranean Diet Nutrition Education Program for the Reduction of Cardiovascular Disease Risk in the Southeastern U.S.

Evaluating the Efficacy of PECS II Block Versus Axillary Ring Block in Rotator Cuff Repair Patients

The Effect of Power Posing on Timed Up and Go Test Score

Army Training at High Intensity Study